Could start making Omicron-specific Covid vaccine in January: Novavax | Watch
- 2 years ago
On Thursday, Novavax Inc said it could begin commercial manufacturing of a Covid-19 vaccine tailored for the Omicron coronavirus variant in January next year.
Meanwhile, the vaccine manufacturing company is also testing whether its current vaccine works against the variant.
Meanwhile, the vaccine manufacturing company is also testing whether its current vaccine works against the variant.